PRESS RELEASE

BIOTECH UPDATES

Merlin Biotech Receives Another Phase I SBIR To Investigate MER-101 in Head and Neck Cancer

Merlin Biotech Receives Another Phase I SBIR To Investigate MER-101 in Head and Neck Cancer

Merlin Biotech Receives NIH Contract To Test MER-101 In Combination with Checkpoint Inhibitors

Merlin Biotech Receives NIH Contract To Test MER-101 In Combination with Checkpoint Inhibitors